Inventor · disambiguated record
Shawn Qian
Also filed as: QIAN SHAWN
9 granted patents·7 pending applications·46 citations·filing 2014–2023
87Inventor score
Top patents by PatentIndex Score
16 records- 0194US9611252B2Therapeutic inhibitory compoundsLIFESCI PHARMACEUTICALS INC·Filed 2016·Granted Apr 4, 2017·12 cites·20 claims
- 0293US10301284B2Therapeutic inhibitory compoundsLIFESCI PHARMACEUTICALS INC·Filed 2018·Granted May 28, 2019·8 cites·11 claims
- 0392US10259803B2Therapeutic inhibitory compoundsLIFESCI PHARMACEUTICALS INC·Filed 2017·Granted Apr 16, 2019·7 cites·28 claims
- 0491US10781200B2Therapeutic inhibitory compoundsATTUNE PHARMACEUTICALS INC·Filed 2019·Granted Sep 22, 2020·6 cites·13 claims
- 0591US10023557B2Therapeutic inhibitory compoundsLIFESCI PHARMACEUTICALS INC·Filed 2016·Granted Jul 17, 2018·6 cites·41 claims
- 0687US10308637B2Therapeutic inhibitory compoundsLIFESCI PHARMACEUTICALS INC·Filed 2018·Granted Jun 4, 2019·3 cites·42 claims
- 0779US10266515B2Therapeutic inhibitory compoundsLIFESCI PHARMACEUTICALS INC·Filed 2014·Granted Apr 23, 2019·4 cites·16 claims
- 0866US11021463B2Therapeutic inhibitory compoundsATTUNE PHARMACEUTICALS INC·Filed 2019·Granted Jun 1, 2021·0 cites·14 claims
- 0963US2021395221A1Therapeutic inhibitory compoundsATTUNE PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 1061US2025145599A1Certain chemical entities, compositions, and methodsRETUNE PHARMA INC·Filed 2023·Application pending·0 cites
- 1151US2020031799A1Therapeutic inhibitory compoundsLIFESCI PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 1240US10981893B2Therapeutic inhibitory compoundsATTUNE PHARMACEUTICALS INC·Filed 2016·Granted Apr 20, 2021·0 cites·2 claims
- 1339US2019292155A1Therapeutic inhibitory compoundsLIFESCI PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 1438US2020405708A1Treatment of hereditary angioedemaATTUNE PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 1537US2019127366A1Therapeutic inhibitory compoundsLIFESCI PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 1635US2019263818A1Therapeutic inhibitory compoundsLIFESCI PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →